Rafina Innovations Inc. (VICA)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Oct 24, 2025
Rafina Innovations Market Cap
Rafina Innovations has a market cap or net worth of $41.69 thousand as of October 24, 2025. Its market cap has decreased by -96.59% in one year.
Market Cap
41.69K
Enterprise Value
n/a
Revenue
335.15K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 23, 2013, Rafina Innovations's market cap has decreased from 2.49M to 41.69K, a decrease of -98.32%. That is a compound annual growth rate of -28.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 41.69K | 29,895.68% |
| Dec 28, 2023 | 139.00 | -99.93% |
| Dec 30, 2022 | 208.47K | -86.36% |
| Dec 31, 2021 | 1.53M | -22.00% |
| Dec 31, 2020 | 1.96M | 41.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 649.45M |
| Glass House Brands | 618.32M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| Northwest Biotherapeutics | 305.00M |
| American Oncology Network | 297.14M |